Skip to content
Home
About us
Co-founders
Our Team
Our Product Pipeline
Our Technology
Scientific Advisors
Investors
Science
AMD and Eyecyte-RPE
TM
Retinitis pigmentosa and Eyecyte-PRP
TM
AAV – mediated gene therapy
Publications
Resources
News and Media
Recognition
Collaborations
Research Alliance
Careers
Contact Us
Home
About us
Co-founders
Our Team
Our Product Pipeline
Our Technology
Scientific Advisors
Investors
Science
AMD and Eyecyte-RPE
TM
Retinitis pigmentosa and Eyecyte-PRP
TM
AAV – mediated gene therapy
Publications
Resources
News and Media
Recognition
Collaborations
Research Alliance
Careers
Contact Us
Eyestem announces US operations with appointment of Ravi Achar and engagement of Stradling advisors
Home
home_banner
Eyestem announces US operations with appointment of Ravi Achar and engagement of Stradling advisors
Post Author:
eyetem@admin
Post navigation
Previous Post
Eyestem raises Series A round from Biological E, Alkem, NATCO, Kemwell promoters and existing investors- Kotak and Endiya
Next Post
Eyestem bags the top innovator award in the country across all categories at the prestigious Economic Times awards
